Dr. Faye Johnson, MD

• Medical Oncology

• Internal Medicine

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• University Of Tex Md Anderson Cancer Center

  Fellowship Hospital

• Baylor College Of Medicine

  Internship Hospital, 1997

• University Of Texas Health Sciences Center At Houston Mcgovern Medical School

  Medical School, 1996

• Mutations of the LIM protein AJUBA mediate sensitivity of head and neck squamous cell carcinoma to treatment with cell-cycle inhibitors, 2017-01-23

• Gene mutations in primary tumors and corresponding patient-derived xenografts derived from non-small cell lung cancer, 2014-11-18

• PDK1 mediatesNOTCH1-mutated head and neck squamous carcinoma vulnerability to therapeutic PI3K/mTOR inhibition, 2019-02-15

• Conditional Survival Among Patients With Oropharyngeal Cancer Treated With Radiation Therapy and Alive Without Recurrence 5 Years After Diagnosis, 2020-12-11

• Phase 1/1b dose escalation and expansion study of BEZ235, a dual PI3K/mTOR inhibitor, in patients with advanced solid tumors including patients with advanced breast cancer, 2018-06-07

• Swallowing After Primary TORS and Unilateral or Bilateral Radiation for Low- to Intermediate-Risk Tonsil Cancer, 2021-11-16

• Wee-1 kinase inhibition sensitizes high risk HPV+ HNSCC to apoptosis accompanied by downregulation of MCl-1 and XIAP antiapoptotic proteins, 2015-06-29

• A Comprehensive Evaluation of Biomarkers Predictive of Response to PI3K Inhibitors and of Resistance Mechanisms in Head and Neck Squamous Cell Carcinoma, 2014-09-05

• Polo-like kinase 1 inhibition diminishes acquired resistance to epidermal growth factor receptor inhibition in non-small cell lung cancer withT790Mmutations, 2016-06-30

• Outcomes of oral cavity cancer patients treated with surgery followed by postoperative intensity modulated radiation therapy, 2017-07-16

• NOTCH1 Signaling in Head and Neck Squamous Cell Carcinoma, 2020-12-12

• Distinct interactions between c-Src and c-Met in mediating resistance to c-Src inhibition in head and neck cancer, 2010-11-24

• CDKN2A/p16 deletion in head and neck cancer cells is associated with Cdk2 activation, replication stress, and vulnerability to Chk1 inhibition, 2017-12-11

• Combined TRIP13 and Aurora kinase inhibition induces apoptosis in human papillomavirus-driven cancers, 2022-10-14

• Non-canonical cM et regulation by vimentin mediates Plk1 inhibitor-induced apoptosis, 2019-04-30

• Pilot phase II trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck, 2021-06-29

• Kinase ImpairedBRAFMutations Confer Lung Cancer Sensitivity to Dasatinib, 2012-05-30

• Tumor grafts derived from patients with head and neck squamous carcinoma authentically maintain the molecular and histologic characteristics of human cancers, 2013-08-27

• Epithelial-Mesenchymal Transition Predicts Polo-Like Kinase 1 Inhibitor-Mediated Apoptosis in Non-Small Cell Lung Cancer, 2015-11-23

• Prognostic Significance of Combinations of RNA-Dependent Protein Kinase and EphA2 Biomarkers for NSCLC, 2013-01-25

• Drug-induced RAF dimerization is independent ofRASmutation status and does not lead to universal MEK dependence for cell survival in head and neck cancers, 2015-05-07

• Reciprocal regulation of c-Src and STAT3 in non-small cell lung cancer, 2009-10-27

• Regulation of Src Family Kinases in Human Cancers, 2011-04-04

• Impact of neoadjuvant durvalumab with or without tremelimumab on CD8+ tumor lymphocyte density, safety, and efficacy in patients with oropharynx cancer: CIAO trial results, 2020-04-08

• Di fferential S ensitivity A nalysis for R esistant M alignancies (DISARM) identifies common candidate therapies across platinum-resistant cancers, 2018-09-26

• Prognostic significance of pre-treatment neutrophil-to-lymphocyte ratio (NLR) in patients with oropharyngeal cancer treated with radiotherapy, 2020-10-14

• Novel Systemic Treatment Modalities Including Immunotherapy and Molecular Targeted Therapy for Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma, 2022-07-17

• Global evaluation of Eph receptors and ephrins in lung adenocarcinomas identifies EphA4 as an inhibitor of cell migration and invasion, 2012-07-17

• Dasatinib induces DNA damage and activates DNA repair pathways leading to senescence in non-small cell lung cancer cell lines with kinase-inactivatingBRAFmutations, 2015-11-23

• Dinaciclib Induces Anaphase Catastrophe in Lung Cancer Cells via Inhibition of Cyclin Dependent Kinases 1 and 2, 2016-08-22

• Phase I study of the combination of crizotinib (as a MET inhibitor) and dasatinib (as a c-SRC inhibitor) in patients with advanced cancer, 2017-10-19

• Epidermal Growth Factor Receptor Expression and Gene Copy Number in the Risk of Oral Cancer, 2010-06-22

• Sustained Aurora kinase B expression confers resistance to PI3K inhibition in head and neck squamous carcinoma, 2022-12-02

• Lymphopenia During Radiotherapy In Patients With Oropharyngeal Cancer, 2020-01-10

• Correction: Tumor grafts derived from patients with head and neck squamous carcinoma authentically maintain the molecular and Histologic characteristics of human cancers, 2014-03-13

• Sustained Src Inhibition Results in STAT3 Activation and Cancer Cell Survival via Altered JAK-STAT3 Binding, 2009-02-17

• STAT5A-mediated SOCS2 expression regulates Jak2 and STAT3 activity following c-Src inhibition in head and neck squamous carcinoma, 2011-11-16

• Protein expression of TTF1 and cMYC define distinct molecular subgroups of small cell lung cancer with unique vulnerabilities to aurora kinase inhibition, DLL3 targeting, and other targeted therapies, 2017-09-01

• Genomic characterization of human papillomavirus-positive and -negative human squamous cell cancer cell lines, 2017-09-21

• Inhibition of nonsense-mediated decay rescues p53ß/? isoform expression and activates the p53 pathway in MDM2-overexpressing and select p53-mutant cancers, 2021-09-03

• Radiation Therapy (with or without neck surgery) for Phenotypic HPV- associated Oropharyngeal Cancer, 2016-03-28